Duell - Promising start for the fiscal year

Name: Evli
Price range: $

Duell's results exceeded our estimates for revenue and adj. EBITA. The revenue beat was largely due to our cautious net sales estimates for Rest of Europe.

Q1 figures were above our estimates

The company reported net sales of EUR 27.0m in Q1 (Q1/23: EUR 25.8m, Evli: EUR 24.5m). Net sales in the Nordics were EUR 15.1m (Q1/23: EUR 16.0m, Evli: EUR 15.2m), while net sales in Rest of Europe were EUR 11.9m (Q1/23: EUR 9.7m, Evli: EUR 9.3m). For Rest of Europe, our prediction for both organic and inorganic net sales development were too conservative. With the higher sales, the adj. EBITA was slightly higher than we estimated at EUR 0.3m (Evli: EUR 0.0m), as the company was able to improve its gross margin and had a lower comparable cost base. Due to seasonality, the company’s NWC and net debt increased q/q yet were at a lower level when compared to Q1 2023.

End-market to remain challenging throughout the FY 2024

Duell maintained its outlook for FY 2024; Duell will keep up its programme to improve profitability and strengthen the net working capital position in financial year 2024. Duell expects adjusted EBITA to increase from the level of the previous year. With the higher than anticipated organic and inorganic net sales growth in Rest of Europe, we raise our estimates especially for Q2/24 as Tran-Am acquisition will keep contributing to inorganic sales growth. The adjustments for the FY 2024 estimate are minor, we raise our net sales estimate to EUR 120.1m (prev. EUR 117.7m) and adj. EBITA to EUR 6.0m (prev. EUR 5.9m). We still anticipate soft market conditions for the whole of FY 2024 as the end-market is expected to stay weak and dealers persist in their cautious inventory management approach. In addition, the current geopolitical tensions bring upside risk to logistics costs.

HOLD with a TP of EUR 0.04 (0.04)

With no major changes to our estimates, the 2024E multiples remain elevated. On the other hand, the 2025 adj. P/E and EV/EBITA imply a discount of 5-20% relative to our main peer group and DCF indicates an upside of 26%. Considering the strengthened balance sheet post-RI and a positive start to the FY, we base our valuation on 24-25E multiples along with DCF.

Open Report